FDA — authorised 30 August 1976
- Status: approved
🇺🇸 Duranest in United States
FDA authorised Duranest on 30 August 1976
Marketing authorisations
FDA — authorised 30 August 1976
- Application: NDA021384
- Marketing authorisation holder: DENTSPLY PHARM
- Local brand name: DURANEST
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 30 August 1976
- Application: NDA017751
- Marketing authorisation holder: ASTRAZENECA
- Local brand name: DURANEST
- Indication: INJECTABLE — INJECTION
- Status: approved
Duranest in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Duranest approved in United States?
Yes. FDA authorised it on 30 August 1976; FDA authorised it on 30 August 1976; FDA authorised it on 30 August 1976.
Who is the marketing authorisation holder for Duranest in United States?
Marketing authorisation holder not available in our data.